Search Results - "Lynch, Peter M."

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada by Alshannaq, Hamza, Isitt, John J, Pollock, Richard F, Norman, Gregory J, Cogswell, Greg, Lynch, Peter M, Roze, Stéphane

“…Aim: Clinical trials and real-world data for Type 2 diabetes have shown that real-time continuous glucose monitoring (rt-CGM) lowers glycated hemoglobin (A1c)…”
Get full text

141-LB: Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) from a U.S. Payer Perspective in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (PwT2D on MDI) by ALSHANNAQ, HAMZA, NORMAN, GREGORY J., LYNCH, PETER M.

“…Diabetes management for PwT2D on MDI requires access to timely glucose readings to inform treatment decisions and avoid acute events like severe hypoglycemia…”
Get full text

134-OR: Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System vs. Self-Monitoring of Blood Glucose in Type 2 Diabetes Patients on Insulin in Canada by ISITT, JOHN J., ROZE, STEPHANE, COGSWELL, GREGORY, LYNCH, PETER M.

“…A health economic analysis was conducted to determine the cost-effectiveness of a real-time continuous glucose monitoring (rt-CGM) system versus…”
Get full text

Cost‐utility of real‐time continuous glucose monitoring versus self‐monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark by Alshannaq, Hamza, Cogswell, Greg, Pollock, Richard F., Ahmed, Waqas, Norman, Greg J., Lynch, Peter M., Roze, Stephane

“…Aims To determine the cost‐effectiveness of the Dexcom G6 real‐time continuous glucose monitoring (rt‐CGM) system compared with both the self‐monitoring of…”
Get full text

77-LB: A Retrospective Analysis of the Association between HbA1c and Continuous Glucose Monitor Use for U.S. Patients with Type 2 Diabetes by NORMAN, GREGORY J., PAUDEL, MISTI L., BANCROFT, TIM, LYNCH, PETER M.

“…Background: Use of real-time continuous glucose monitoring (rtCGM) reduces HbA1c in individuals with type 2 diabetes (T2D) treated with intensive insulin…”
Get full text

66-LB: Real-Time Continuous Glucose Monitor (RTCGM) Use Associated with Decreased Diabetes Medical Costs for Patients with Type 2 Diabetes (T2D) by NORMAN, GREGORY J., PAUDEL, MISTI L., BANCROFT, TIM, LYNCH, PETER M.

“…Background: RtCGM allows patients with type 2 diabetes to improve blood glucose control and reduce risk of serious acute and chronic complications of diabetes…”
Get full text

174-OR: Budget Impact Analysis (BIA) Comparing Real-Time Continuous Glucose Monitoring (RT-CGM) with Self-Monitoring of Blood Glucose (SMBG) for all U.S. Medicaid Enrollees with Type 1 Diabetes by MINSHALL, MICHAEL E., ISITT, JOHN J., GRAHAM, CLAUDIA, LYNCH, PETER M.

“…A BIA was performed comparing clinical cost offsets for rt-CGM compared with SMBG for U.S. Medicaid enrollees with type 1 diabetes (T1D) over one year…”
Get full text

Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK by Isitt, John J., Roze, Stéphane, Sharland, Helen, Cogswell, Greg, Alshannaq, Hamza, Norman, Gregory J., Lynch, Peter M.

“…Introduction Real-time continuous glucose monitoring (rt-CGM) involves the measurement and display of glucose concentrations, potentially improving glucose…”
Get full text

67-LB: Clinical Cost Offset Analysis Comparing Real-Time CGM (RTCGM) with SMBG Based on the COMISAIR 3-Year Follow-Up Study by SOUPAL, JAN, ISITT, JOHN J., GRUNBERGER, GEORGE, PRAZNY, MARTIN, PARKIN, CHRISTOPHER, MINSHALL, MICHAEL E., LYNCH, PETER M.

“…This clinical cost offset analysis compared rtCGM vs. SMBG in people with type 1 diabetes (T1D) applying results from a 3-year, nonrandomized, prospective,…”
Get full text

68-LB: Use of Real-Time CGM Is Associated with Fewer Hospitalizations Compared with SMBG in the Insulin-Treated Medicare Population by PUCKREIN, GARY, MARRERO, DAVID G., PARKIN, CHRISTOPHER, NORMAN, GREGORY J., XU, LIOU, LYNCH, PETER M., TAYLOR, BRUCE T.

“…The Centers for Medicare and Medicaid (CMS) only allows coverage of CGM for beneficiaries with diabetes who are treated with insulin, (insulin injections…”
Get full text

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France by Alshannaq, Hamza, Pollock, Richard F, Joubert, Michael, Ahmed, Waqas, Norman, Gregory J, Lynch, Peter M, Roze, Stéphane

“…Clinical trials and real-world data for Type II diabetes both show that glycated hemoglobin (HbA1c) levels and hypoglycemia occurrence can be reduced by…”
Get full text

Resource utilization with insulin pump therapy for type 2 diabetes mellitus by Lynch, Peter M, Riedel, Aylin Altan, Samant, Navendu, Fan, Ying, Peoples, Tim, Levinson, Jennifer, Lee, Scott W

“…To evaluate the effects of switching from multiple daily injection (MDI) therapy to insulin pump therapy, also called continuous subcutaneous insulin infusion…”
Get full text

1035-P: Cost-Effectiveness of Real-Time CGM vs. Self-Monitoring of Blood Glucose in People with Insulin-Treated Type 2 Diabetes from a U.S. Payor Perspective by Alshannaq, Hamza, Norman, Gregory J, Lynch, Peter M

“…Introduction: Diabetes and its complications cost the US healthcare system $412.9 billion in 2022. The use of RT-CGM systems in diabetes management is…”
Get full text

Hidradenitis suppurativa: A comprehensive review by Alikhan, Ali, Lynch, Peter J., MD, Eisen, Daniel B., MD

“…Hidradenitis suppurativa, also known as acne inversa, is a chronic, often debilitating disease primarily affecting the axillae, perineum, and inframammary…”
Get full text

Acrodermatitis enteropathica and an overview of zinc metabolism by Maverakis, Emanual, MD, Fung, Maxwell A., MD, Lynch, Peter J., MD, Draznin, Michelle, MD, Michael, Daniel J., MD, PhD, Ruben, Beth, MD, Fazel, Nasim, MD, DDS

“…Acrodermatitis enteropathica is a rare autosomal recessive disorder of zinc deficiency. The genetic defect has been mapped to 8q24 and the defective gene…”
Get full text

Chronic atrophic erosive dermatosis of the scalp and extremities: A recharacterization of erosive pustular dermatosis by Patton, Douglas, MD, Lynch, Peter J., MD, Fung, Maxwell A., MD, Fazel, Nasim, MD, DDS

“…Background Erosive pustular dermatosis (EPD) is a rarely reported condition that primarily involves the actinically damaged scalp of elderly women. Although…”
Get full text

Thymoma-associated multiorgan autoimmunity: A graft-versus-host–like disease by Wadhera, Akhil, MD, Maverakis, Emanual, MD, Mitsiades, Nicholas, MD, Lara, Primo N., MD, Fung, Maxwell A., MD, Lynch, Peter J., MD

“…Graft-versus-host disease (GVHD) is a T cell–mediated disease seen most commonly after hematopoietic stem cell transplantation. Rarely, a GVHD-like disease can…”
Get full text

Coronary heart disease in British soldiers by Lynch, Peter M. D

“…The aim of this thesis is to present evidence that young soldiers in the British army have a higher mortality from coronary heart disease (CHD) than the civil…”
Get full text